Dong Nguyen, Quan http://orcid.org/0000-0002-6024-8441
Ehlers, Justis P. http://orcid.org/0000-0001-6763-7768
Boyer, David S.
Jin, Xidong
Giani, Andrea
Ehrlich, Michael S.
,
Brucker, Alexander
Hu, Allen
Fawzi, Amani
Antoszyk, Andrew
Berger, Brian
Jhaveri, Chirag
Bailey, Claire
Brown, David
Kunimoto, Derek
Ghanchi, Faruque
Bandello, Francesco
Menon, Geeta
Sen, Harsha
Talks, James
Figueira, João
Barranco, Jose Juan Escobar
Donate Lopez, Juan
Habib, Maged
Erke, Maja Gran
Weger, Martin
Cunningham, Matthew
Varano, Monica
Manjunatha, Nonavinakere
Hahn, Paul
Calvo, Pilar
Dugel, Pravin
Maturi, Raj
Rosen, Richard
Silva, Rufino
Pagliarini, Sergio
Sivaprasad, Sobha
Androudi, Sofia
Patel, Sunil
,
,
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 11 September 2023
Revised: 16 January 2024
Accepted: 6 March 2024
First Online: 28 May 2024
Competing interests
: QDN declares funding from Boehringer Ingelheim, Genentech, Gilead, Regeneron and Santen, and consulting for Genentech, Novartis, Regeneron and Santen. JPE declares that he is a consultant for Adverum, Aerpio, Alcon, Allergan, Boehringer Ingelheim, Genentech, Leica, Novartis, Regeneron, Roche, Stealth and Zeiss, and receives grant support from Adverum, Alcon, Allergan, Boehringer Ingelheim, Novartis, Roche, Regeneron, Stealth and Zeiss. DSB declares that he is a consultant with Acucela, Alimera Sciences, Allegro, Bayer, EyePoint Pharmaceuticals, ONL Therapeutics, Oxurion and Takeda; is a consultant and researcher with Adverum, Aerpio, Allergan, Apellis, Boehringer Ingelheim, Chengdu Kanghong, Clearside Biomedical, Genentech/Roche, Kodiak, Novartis, Regeneron, REGENXBIO, Roche and Santen; and is a researcher with Aerie Pharmaceuticals, Gemini Therapeutics, Graybug Vision, IONIS Pharmaceuticals, Neurotech, Opthea and Outlook Therapeutics. XJ and AG declare that they are employees of Boehringer Ingelheim. MSE declares that he is an employee of Alexion Pharmaceuticals, but that this work was performed prior to Alexion employment and is not endorsed by Alexion; at the time of project initiation, he was an employee of Boehringer Ingelheim.